Format
Sort by
Items per page

Send to

Choose Destination

Best matches for Schüpbach M[au]:

Summary of the recommendations of the EFNS/MDS-ES review on therapeutic management of Parkinson's disease. Ferreira JJ et al. Eur J Neurol. (2013)

[Deep brain stimulation]. Benninger D et al. Ther Umsch. (2018)

Deep Brain Stimulation for Tremor: Is There a Common Structure? Fiechter M et al. Stereotact Funct Neurosurg. (2017)

Search results

Items: 1 to 50 of 63

1.

Effects of bilateral stimulation of the subthalamic nucleus in Parkinson's disease with and without REM sleep behaviour disorder.

Bargiotas P, Debove I, Bargiotas I, Lachenmayer ML, Ntafouli M, Vayatis N, Schüpbach MW, Krack P, Bassetti CL.

J Neurol Neurosurg Psychiatry. 2019 Aug 17. pii: jnnp-2019-320858. doi: 10.1136/jnnp-2019-320858. [Epub ahead of print]

PMID:
31422368
2.

Analysis of patient-specific stimulation with segmented leads in the subthalamic nucleus.

Nguyen TAK, Djilas M, Nowacki A, Mercanzini A, Schüpbach M, Renaud P, Pollo C.

PLoS One. 2019 Jun 19;14(6):e0217985. doi: 10.1371/journal.pone.0217985. eCollection 2019.

3.

Directional stimulation of subthalamic nucleus sweet spot predicts clinical efficacy: Proof of concept.

Nguyen TAK, Nowacki A, Debove I, Petermann K, Tinkhauser G, Wiest R, Schüpbach M, Krack P, Pollo C.

Brain Stimul. 2019 Sep - Oct;12(5):1127-1134. doi: 10.1016/j.brs.2019.05.001. Epub 2019 May 17.

PMID:
31130498
4.

Stimulation of the globus pallidus internus in the treatment of Parkinson's disease: Long-term results of a monocentric cohort.

Lachenmayer ML, Bettschen C, Bernasconi C, Petermann K, Debove I, Muellner J, Michelis JP, Burgunder JM, Krauss JK, Oertel MF, Pollo C, Kaelin-Lang A, Schüpbach M.

Parkinsonism Relat Disord. 2019 Jul;64:118-123. doi: 10.1016/j.parkreldis.2019.03.009. Epub 2019 Mar 16.

PMID:
30935828
5.

Targeting the posterior subthalamic area for essential tremor: proposal for MRI-based anatomical landmarks.

Nowacki A, Debove I, Rossi F, Schlaeppi JA, Petermann K, Wiest R, Schüpbach M, Pollo C.

J Neurosurg. 2018 Oct 1:1-8. doi: 10.3171/2018.4.JNS18373. [Epub ahead of print]

PMID:
30497206
6.

Reply to "The paper that wrote itself-a ghost story".

Schüpbach M, Chabardes S, Matthies C, Pollo C, Steigerwald F, Timmermann L, Visser Vandewalle V, Volkmann J, Schuurman PR.

Mov Disord. 2018 Sep;33(9):1510-1511. doi: 10.1002/mds.27464. Epub 2018 Sep 7. No abstract available.

PMID:
30192032
7.

Behavioural outcomes of subthalamic stimulation and medical therapy versus medical therapy alone for Parkinson's disease with early motor complications (EARLYSTIM trial): secondary analysis of an open-label randomised trial.

Lhommée E, Wojtecki L, Czernecki V, Witt K, Maier F, Tonder L, Timmermann L, Hälbig TD, Pineau F, Durif F, Witjas T, Pinsker M, Mehdorn M, Sixel-Döring F, Kupsch A, Krüger R, Elben S, Chabardès S, Thobois S, Brefel-Courbon C, Ory-Magne F, Regis JM, Maltête D, Sauvaget A, Rau J, Schnitzler A, Schüpbach M, Schade-Brittinger C, Deuschl G, Houeto JL, Krack P; EARLYSTIM study group.

Lancet Neurol. 2018 Mar;17(3):223-231. doi: 10.1016/S1474-4422(18)30035-8.

PMID:
29452685
8.

[Deep brain stimulation].

Benninger D, Schüpbach M.

Ther Umsch. 2018;75(7):425-431. doi: 10.1024/0040-5930/a001019. Review. German.

PMID:
30935352
9.

Targeting Accuracy of the Subthalamic Nucleus in Deep Brain Stimulation Surgery: Comparison Between 3 T T2-Weighted Magnetic Resonance Imaging and Microelectrode Recording Results.

Nowacki A, Debove I, Fiechter M, Rossi F, Oertel MF, Wiest R, Schüpbach M, Pollo C.

Oper Neurosurg (Hagerstown). 2018 Jul 1;15(1):66-71. doi: 10.1093/ons/opx175.

PMID:
28973406
10.

Deep Brain Stimulation for Tremor: Is There a Common Structure?

Fiechter M, Nowacki A, Oertel MF, Fichtner J, Debove I, Lachenmayer ML, Wiest R, Bassetti CL, Raabe A, Kaelin-Lang A, Schüpbach MW, Pollo C.

Stereotact Funct Neurosurg. 2017;95(4):243-250. doi: 10.1159/000478270. Epub 2017 Aug 4.

11.

T2-relaxometry predicts outcome of DBS in idiopathic Parkinson's disease.

Lönnfors-Weitzel T, Weitzel T, Slotboom J, Kiefer C, Pollo C, Schüpbach M, Oertel M, Kaelin A, Wiest R.

Neuroimage Clin. 2016 Sep 29;12:832-837. eCollection 2016.

12.

Correction: Bee Venom for the Treatment of Parkinson Disease - A Randomized Controlled Clinical Trial.

Hartmann A, Muellner J, Meier N, Hesekamp H, van Meerbeeck P, Habert MO, Kas A, Tanguy ML, Mazmanian M, Oya H, Abuaf N, Gaouar H, Salhi S, Charbonnier-Beaupel F, Fievet MH, Galanaud D, Arguillere S, Roze E, Degos B, Grabli D, Lacomblez L, Hubsch C, Vidailhet M, Bonnet AM, Corvol JC, Schüpbach M.

PLoS One. 2016 Sep 8;11(9):e0162937. doi: 10.1371/journal.pone.0162937. eCollection 2016.

13.

Bee Venom for the Treatment of Parkinson Disease - A Randomized Controlled Clinical Trial.

Hartmann A, Müllner J, Meier N, Hesekamp H, van Meerbeeck P, Habert MO, Kas A, Tanguy ML, Mazmanian M, Oya H, Abuaf N, Gaouar H, Salhi S, Charbonnier-Beaupel F, Fievet MH, Galanaud D, Arguillere S, Roze E, Degos B, Grabli D, Lacomblez L, Hubsch C, Vidailhet M, Bonnet AM, Corvol JC, Schüpbach M.

PLoS One. 2016 Jul 12;11(7):e0158235. doi: 10.1371/journal.pone.0158235. eCollection 2016. Erratum in: PLoS One. 2016;11(9):e0162937.

14.

Effects of Exergaming on Physical Activity in Overweight Individuals.

Höchsmann C, Schüpbach M, Schmidt-Trucksäss A.

Sports Med. 2016 Jun;46(6):845-60. doi: 10.1007/s40279-015-0455-z. Review.

PMID:
26712512
15.

Referring Parkinson's disease patients for deep brain stimulation: a RAND/UCLA appropriateness study.

Moro E, Schüpbach M, Wächter T, Allert N, Eleopra R, Honey CR, Rueda M, Schiess MC, Shimo Y, Valkovic P, Whone A, Stoevelaar H.

J Neurol. 2016 Jan;263(1):112-9. doi: 10.1007/s00415-015-7942-x. Epub 2015 Nov 3.

16.

Using MDEFT MRI Sequences to Target the GPi in DBS Surgery.

Nowacki A, Fiechter M, Fichtner J, Debove I, Lachenmayer L, Schüpbach M, Oertel MF, Wiest R, Pollo C.

PLoS One. 2015 Sep 14;10(9):e0137868. doi: 10.1371/journal.pone.0137868. eCollection 2015.

17.

Allogeneic haematopoietic stem cell transplantation for mitochondrial neurogastrointestinal encephalomyopathy.

Halter JP, Michael W, Schüpbach M, Mandel H, Casali C, Orchard K, Collin M, Valcarcel D, Rovelli A, Filosto M, Dotti MT, Marotta G, Pintos G, Barba P, Accarino A, Ferra C, Illa I, Beguin Y, Bakker JA, Boelens JJ, de Coo IF, Fay K, Sue CM, Nachbaur D, Zoller H, Sobreira C, Pinto Simoes B, Hammans SR, Savage D, Martí R, Chinnery PF, Elhasid R, Gratwohl A, Hirano M.

Brain. 2015 Oct;138(Pt 10):2847-58. doi: 10.1093/brain/awv226. Epub 2015 Aug 10.

18.

Altered structure of cortical sulci in gilles de la Tourette syndrome: Further support for abnormal brain development.

Muellner J, Delmaire C, Valabrégue R, Schüpbach M, Mangin JF, Vidailhet M, Lehéricy S, Hartmann A, Worbe Y.

Mov Disord. 2015 Apr 15;30(5):655-61. doi: 10.1002/mds.26207. Epub 2015 Mar 26.

PMID:
25820811
19.

International validation of a behavioral scale in Parkinson's disease without dementia.

Rieu I, Martinez-Martin P, Pereira B, De Chazeron I, Verhagen Metman L, Jahanshahi M, Ardouin C, Chéreau I, Brefel-Courbon C, Ory-Magne F, Klinger H, Peyrol F, Schupbach M, Dujardin K, Tison F, Houeto JL, Krack P, Durif F.

Mov Disord. 2015 Apr 15;30(5):705-13. doi: 10.1002/mds.26223. Epub 2015 Mar 21.

PMID:
25809278
20.

Bladder function in patients with dystonia undergoing deep brain stimulation.

Mordasini L, Kessler TM, Kiss B, Schüpbach M, Pollo C, Kaelin-Lang A.

Parkinsonism Relat Disord. 2014 Sep;20(9):1015-7. doi: 10.1016/j.parkreldis.2014.05.016. Epub 2014 Jun 14.

PMID:
24984838
21.

The Clinical Spectrum of Ataxia with Oculomotor Apraxia Type 2.

Brugger F, Schüpbach M, Koenig M, Müri R, Bohlhalter S, Kaelin-Lang A, Kamm CP, Kägi G.

Mov Disord Clin Pract. 2014 May 27;1(2):106-109. doi: 10.1002/mdc3.12021. eCollection 2014 Jun.

22.

Directional deep brain stimulation: an intraoperative double-blind pilot study.

Pollo C, Kaelin-Lang A, Oertel MF, Stieglitz L, Taub E, Fuhr P, Lozano AM, Raabe A, Schüpbach M.

Brain. 2014 Jul;137(Pt 7):2015-26. doi: 10.1093/brain/awu102. Epub 2014 May 19.

PMID:
24844728
23.

Optimal target localization for subthalamic stimulation in patients with Parkinson disease.

Welter ML, Schüpbach M, Czernecki V, Karachi C, Fernandez-Vidal S, Golmard JL, Serra G, Navarro S, Welaratne A, Hartmann A, Mesnage V, Pineau F, Cornu P, Pidoux B, Worbe Y, Zikos P, Grabli D, Galanaud D, Bonnet AM, Belaid H, Dormont D, Vidailhet M, Mallet L, Houeto JL, Bardinet E, Yelnik J, Agid Y.

Neurology. 2014 Apr 15;82(15):1352-61. doi: 10.1212/WNL.0000000000000315. Epub 2014 Mar 19.

24.

A new rechargeable device for deep brain stimulation: a prospective patient satisfaction survey.

Timmermann L, Schüpbach M, Hertel F, Wolf E, Eleopra R, Franzini A, Servello D, Skogseid IM, Rumia J, Aliaga AS, Barbe MT, Pauls KA, Lin JP, Moro E, Lloyd A, Maarouf M.

Eur Neurol. 2013;69(4):193-9. doi: 10.1159/000342236. Epub 2013 Jan 10.

PMID:
23328107
25.

Summary of the recommendations of the EFNS/MDS-ES review on therapeutic management of Parkinson's disease.

Ferreira JJ, Katzenschlager R, Bloem BR, Bonuccelli U, Burn D, Deuschl G, Dietrichs E, Fabbrini G, Friedman A, Kanovsky P, Kostic V, Nieuwboer A, Odin P, Poewe W, Rascol O, Sampaio C, Schüpbach M, Tolosa E, Trenkwalder C, Schapira A, Berardelli A, Oertel WH.

Eur J Neurol. 2013 Jan;20(1):5-15. doi: 10.1111/j.1468-1331.2012.03866.x. Review.

PMID:
23279439
26.

Effects of dopaminergic and subthalamic stimulation on musical performance.

van Vugt FT, Schüpbach M, Altenmüller E, Bardinet E, Yelnik J, Hälbig TD.

J Neural Transm (Vienna). 2013 May;120(5):755-9. doi: 10.1007/s00702-012-0923-7. Epub 2012 Dec 12.

PMID:
23232663
27.

Stimulation of the subthalamic nucleus at an earlier disease stage of Parkinson's disease: concept and standards of the EARLYSTIM-study.

Deuschl G, Schüpbach M, Knudsen K, Pinsker MO, Cornu P, Rau J, Agid Y, Schade-Brittinger C.

Parkinsonism Relat Disord. 2013 Jan;19(1):56-61. doi: 10.1016/j.parkreldis.2012.07.004. Epub 2012 Jul 28.

PMID:
22841616
28.

Repetitive behaviours in patients with Gilles de la Tourette syndrome: tics, compulsions, or both?

Worbe Y, Mallet L, Golmard JL, Béhar C, Durif F, Jalenques I, Damier P, Derkinderen P, Pollak P, Anheim M, Broussolle E, Xie J, Mesnage V, Mondon K, Viallet F, Jedynak P, Ben Djebara M, Schüpbach M, Pelissolo A, Vidailhet M, Agid Y, Houeto JL, Hartmann A.

PLoS One. 2010 Sep 24;5(9):e12959. doi: 10.1371/journal.pone.0012959.

29.

Long-standing paraphilia induced by dopamine agonists in Parkinson's disease.

Pineau F, Schüpbach M, Corvol JC, Flamand-Rouvière C, Vidailhet M, Roze E.

Mov Disord. 2010 May 15;25(7):963-5. doi: 10.1002/mds.23039. No abstract available.

PMID:
20461818
30.

Parkinsonism in Gaucher's disease type 1: ten new cases and a review of the literature.

Kraoua I, Stirnemann J, Ribeiro MJ, Rouaud T, Verin M, Annic A, Rose C, Defebvre L, Réménieras L, Schüpbach M, Belmatoug N, Vidailhet M, Sedel F.

Mov Disord. 2009 Jul 30;24(10):1524-30. doi: 10.1002/mds.22593. Review.

PMID:
19513999
31.

A three-dimensional histological atlas of the human basal ganglia. II. Atlas deformation strategy and evaluation in deep brain stimulation for Parkinson disease.

Bardinet E, Bhattacharjee M, Dormont D, Pidoux B, Malandain G, Schüpbach M, Ayache N, Cornu P, Agid Y, Yelnik J.

J Neurosurg. 2009 Feb;110(2):208-19. doi: 10.3171/2008.3.17469.

PMID:
18976051
32.

A multicentre study on suicide outcomes following subthalamic stimulation for Parkinson's disease.

Voon V, Krack P, Lang AE, Lozano AM, Dujardin K, Schüpbach M, D'Ambrosia J, Thobois S, Tamma F, Herzog J, Speelman JD, Samanta J, Kubu C, Rossignol H, Poon YY, Saint-Cyr JA, Ardouin C, Moro E.

Brain. 2008 Oct;131(Pt 10):2720-8. doi: 10.1093/brain/awn214.

33.

Apathy following subthalamic stimulation in Parkinson disease: a dopamine responsive symptom.

Czernecki V, Schüpbach M, Yaici S, Lévy R, Bardinet E, Yelnik J, Dubois B, Agid Y.

Mov Disord. 2008 May 15;23(7):964-969. doi: 10.1002/mds.21949.

PMID:
18398913
34.

Disconnecting force from money: effects of basal ganglia damage on incentive motivation.

Schmidt L, d'Arc BF, Lafargue G, Galanaud D, Czernecki V, Grabli D, Schüpbach M, Hartmann A, Lévy R, Dubois B, Pessiglione M.

Brain. 2008 May;131(Pt 5):1303-10. doi: 10.1093/brain/awn045. Epub 2008 Mar 15.

PMID:
18344560
35.

Aripiprazole: a treatment for severe coprolalia in "refractory" Gilles de la Tourette syndrome.

Ben Djebara M, Worbe Y, Schüpbach M, Hartmann A.

Mov Disord. 2008 Feb 15;23(3):438-40.

PMID:
18067182
36.

Stimulation of subterritories of the subthalamic nucleus reveals its role in the integration of the emotional and motor aspects of behavior.

Mallet L, Schüpbach M, N'Diaye K, Remy P, Bardinet E, Czernecki V, Welter ML, Pelissolo A, Ruberg M, Agid Y, Yelnik J.

Proc Natl Acad Sci U S A. 2007 Jun 19;104(25):10661-6. Epub 2007 Jun 7.

37.

Mortality in patients with Parkinson's disease treated by stimulation of the subthalamic nucleus.

Schüpbach MW, Welter ML, Bonnet AM, Elbaz A, Grossardt BR, Mesnage V, Houeto JL, Maltête D, Mallet L, Rocca WA, Mallet A, Agid Y.

Mov Disord. 2007 Jan 15;22(2):257-61.

PMID:
17149702
38.

[Neurological manifestations of type 1 Gaucher's disease: Is a revision of disease classification needed?].

Chérin P, Sedel F, Mignot C, Schupbach M, Gourfinkel-An I, Verny M, Baumann N.

Rev Neurol (Paris). 2006 Nov;162(11):1076-83. French.

PMID:
17086144
39.

Subthalamic nucleus stimulation is efficacious in patients with Parkinsonism and LRRK2 mutations.

Schüpbach M, Lohmann E, Anheim M, Lesage S, Czernecki V, Yaici S, Worbe Y, Charles P, Welter ML, Pollak P, Dürr A, Agid Y, Brice A.

Mov Disord. 2007 Jan;22(1):119-22.

PMID:
17080443
40.

Neurosurgery in Parkinson's disease: the doctor is happy, the patient less so?

Agid Y, Schüpbach M, Gargiulo M, Mallet L, Houeto JL, Behar C, Maltête D, Mesnage V, Welter ML.

J Neural Transm Suppl. 2006;(70):409-14. Review.

PMID:
17017560
41.

Neurosurgery in Parkinson disease: a distressed mind in a repaired body?

Schüpbach M, Gargiulo M, Welter ML, Mallet L, Béhar C, Houeto JL, Maltête D, Mesnage V, Agid Y.

Neurology. 2006 Jun 27;66(12):1811-6.

PMID:
16801642
42.

An effect of dopamine depletion on decision-making: the temporal coupling of deliberation and execution.

Pessiglione M, Czernecki V, Pillon B, Dubois B, Schüpbach M, Agid Y, Tremblay L.

J Cogn Neurosci. 2005 Dec;17(12):1886-96.

PMID:
16356326
43.

[Pergolide associated valvulopathy: critical analysis of the literature and practical recommendations].

Corvol JC, Schüpbach M, Bonnet AM; Centre d'Investigation Clinique et Fédération des Maladies du Système Nerveux, Hôpital de la Pitié-Salpêtrière, Paris.

Rev Neurol (Paris). 2005 Jul;161(6-7):637-43. Review. French.

PMID:
16141947
44.
45.

Standardization of the Tübingen flicker test.

Trauzettel-Klosinski S, Schüpbach M, Aulhorn E.

Graefes Arch Clin Exp Ophthalmol. 1989;227(3):221-9.

PMID:
2737483
46.

Mutagenicity testing experiments with the Cobas Bact.

Gocke E, Schüpbach M.

Mutat Res. 1986 Oct;172(1):1-9.

PMID:
3531833
47.

Preclinical safety evaluation of intravenously administered mixed micelles.

Teelmann K, Schläppi B, Schüpbach M, Kistler A.

Arzneimittelforschung. 1984;34(11):1517-23.

PMID:
6543126
49.

Isolation and characterization of acid phosphatase mutants in Schizosaccharomycespombe.

Schweingruber ME, Schweingruber AM, Schüpbach ME.

Curr Genet. 1982 Jul;5(2):109-17. doi: 10.1007/BF00365701.

PMID:
24186226
50.

An assessment of the potential genotoxicity of four sunscreen agents.

Trueman RW, Schüpbach M.

Prog Clin Biol Res. 1982;109:415-21. No abstract available.

PMID:
7167553

Supplemental Content

Loading ...
Support Center